Staff Engineer - AISW, Software Engineering

A jury in Wilmington, Delaware, failed to reach a verdict in Qualcomm's lawsuit against Arm Holdings after about four hours of deliberation on Friday. It plans to return on Tuesday. Qualcomm says Arm broke their licensing agreements by holding back software patches and tools, and by violating a deal meant to keep Qualcomm's price within 10% of the lowest price for Arm's processor designs. It also says Arm leaked a 2024 letter to Bloomberg to hurt its dealings with Meta. Arm says Qualcomm was "not harmed in the least" and calls the suit a bid for leverage. Qualcomm's licence for Arm's architecture runs until 2033. A separate bench trial is weighing whether Arm negotiates in good faith. That ruling could come well after the verdict.

ARM (NASDAQ:ARM) stock falls 6.5% - what's next? Shares of Arm Holdings PLC Sponsored ADR (NASDAQ:ARM - Get Free Report) traded down 6.5% during mid-day trading on Thursday. The company traded as low as $270.26 and last traded at $275.29. Approximately 6,063,281 shares changed hands during trading, a decline of 21% from the average daily volume of 7,662,422 shares. The stock had previously closed at $294.37. ARM news roundup. Here are the key news stories impacting ARM this week: * Arm's AI opportunity remains a major bullish catalyst. Its architecture is used across major AI platforms, while demand for its flagship CPU reportedly exceeded management's expectations. Shares are up roughly 143% to 177% year to date, reflecting optimism about AI data-center growth. * Lattice Semiconductor is collaborating with Arm to integrate FPGA-based control technology into AI servers. The partnership could strengthen Arm's position in server infrastructure and increase the adoption of its technology in data-center systems. * Arm's recent rebound has renewed interest in the stock, but its approximately 43.5-times forward-sales valuation leaves little room for execution missteps and makes the entry point a key investor concern. * One valuation model places fair value below the then-current share price, while broader analyst targets remain substantially higher. The wide range highlights disagreement over how much of Arm's long-term AI growth is already reflected in the stock. * Reports tied to OpenAI's revenue outlook pressured semiconductor stocks, contributing to weakness in Arm. The concern is that uncertainty around AI spending and monetization could challenge the exceptionally high expectations embedded in AI-related valuations. * Arm and Qualcomm are in a federal trial over licensing and royalty obligations involving Qualcomm chips based on Arm architecture. An unfavorable outcome could affect billions of dollars in royalty payments or future licensing terms. * A short-interest update reported zero shares sold short and a zero-day days-to-cover ratio, indicating no measurable short-position overhang in the cited data, although the figure appears inconsistent with the description of a significant increase. Analyst ratings changes. ARM has been the subject of a number of research analyst reports. Jefferies Financial Group restated a "buy" rating and issued a $320.00 target price on shares of ARM in a report on Monday, July 20th. Royal Bank Of Canada reduced their price objective on ARM from $475.00 to $340.00 and set an "outperform" rating for the company in a research note on Thursday, July 30th. Raymond James Financial restated an "outperform" rating and set a $166.00 price objective on shares of ARM in a research report on Tuesday, August 25th. New Street Research upgraded ARM from a "neutral" rating to a "buy" rating and set a $260.00 target price on the stock in a report on Thursday, July 30th. Finally, Bank of America restated a "neutral" rating and set a $335.00 price target (up from $245.00) on shares of ARM in a report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $303.32. Discover more Nasdaq trading tools Stock market data NYSE stock analysis ARM stock down 3.3%. The company's 50-day simple moving average is $270.11 and its 200 day simple moving average is $265.87. The stock has a market capitalization of $284.41 billion, a price-to-earnings ratio of 274.52, a P/E/G ratio of 8.16 and a beta of 3.78. ARM (NASDAQ:ARM - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.05. The company had revenue of $1.29 billion during the quarter, compared to the consensus estimate of $1.26 billion. ARM had a return on equity of 12.24% and a net margin of 20.25%. The firm's revenue was up 22.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.35 EPS. On average, equities analysts expect that Arm Holdings PLC Sponsored ADR will post 1.15 earnings per share for the current fiscal year. Insider activity at ARM. In other news, CFO Jason Child sold 10,400 shares of the business's stock in a transaction on Monday, September 21st. The shares were sold at an average price of $300.00, for a total value of $3,120,000.00. Following the completion of the sale, the chief financial officer directly owned 153,442 shares in the company, valued at approximately $46,032,600. The trade was a 6.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Institutional inflows and outflows. Several institutional investors have recently bought and sold shares of ARM. Schaper Benz & Wise Investment Counsel Inc. WI increased its stake in shares of ARM by 3.7% in the third quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 38,630 shares of the company's stock worth $11,190,000 after purchasing an additional 1,372 shares during the period. Wedmont Private Capital bought a new stake in ARM during the 3rd quarter valued at approximately $1,322,000. Gainplan LLC bought a new stake in ARM during the 3rd quarter valued at approximately $724,000. Zevenbergen Capital Investments LLC grew its holdings in ARM by 3.2% in the 3rd quarter. Zevenbergen Capital Investments LLC now owns 62,945 shares of the company's stock valued at $18,233,000 after buying an additional 1,980 shares during the last quarter. Finally, Avidian Wealth Enterprises LLC grew its holdings in ARM by 9.7% in the 3rd quarter. Avidian Wealth Enterprises LLC now owns 1,300 shares of the company's stock valued at $377,000 after buying an additional 115 shares during the last quarter. Institutional investors own 7.53% of the company's stock. About ARM. Arm Holdings plc (NASDAQ: ARM) is a semiconductor and software design company that develops intellectual property used to create energy-efficient computing products. Arm does not generally manufacture chips; instead, it licenses processor architectures, CPU cores, graphics technologies and related system IP to semiconductor companies and original equipment manufacturers, which incorporate them into their own products. The company's offerings include the Cortex family of CPUs for mobile, consumer, automotive and embedded applications; Neoverse platforms for cloud and data-center infrastructure; Mali graphics processing units; and Ethos neural processing units designed for artificial intelligence and machine-learning workloads. Further reading. Receive News & Ratings for ARM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARM and related companies with MarketBeat.com's FREE daily email newsletter.

Qualcomm seeks to halt billions in royalties in Arm court battle. October 9, 2026 11:17 pm Business Qualcomm and Arm Holdings returned to a Delaware federal court for a five-day jury trial on Monday, October 5, 2026, as Qualcomm seeks to halt royalty payments for up to five years and accuses Arm of withholding critical testing tools and leaking a 2024 contract threat that damaged chip deal negotiations with Meta Platforms. Federal court battle over billions in royalties and Meta deal fallout. The courtroom showdown in Wilmington, Delaware, marks another chapter in the contentious relationship between two chip giants. Qualcomm, one of Arm's largest customers, alleges that Arm withheld mandatory chip-testing tools owed under their contract and intentionally undermined business negotiations by leaking a 2024 termination threat to the press. According to court arguments, that disclosure of a license breach notification to Bloomberg News rattled Meta Platforms just as Qualcomm was finalizing a major supply agreement. Start an LLC Qualcomm attorney Karen Dunn told the jury that by the time Qualcomm managed to salvage the agreement, the value of the deal had decreased by $170 million due to the disruption and delay. Delay is costly, she told the jury, adding that the case is very serious because Qualcomm's entire chip business depends on Arm honoring its contractual promises. "It's really bad because Qualcomm's entire chip business depends on Arm and on Arm honoring its contract and honoring its promises," Karen Dunn, Qualcomm attorney In the lawsuit, Qualcomm is attempting to halt its royalty payments to Arm for up to five years, a remedy that could be worth billions of dollars. However, U.S. District Judge Maryellen Noreika is weighing whether to strike that specific contractual remedy, a move that would limit the damages Qualcomm can pursue. Arm rejects damage claims and cites shift in virtual reality strategy. Arm strongly denies the breach-of-contract allegations and contends that Qualcomm's claimed financial harm is entirely speculative. Representing Arm, attorney Gregg LoCascio told the jury that Meta shifted its focus away from virtual reality headsets toward AI smart glasses, which naturally altered the financial terms of the chip arrangements rather than any leaked correspondence from Arm. Read Daily News "They were not harmed in the least," Gregg LoCascio, Arm attorney Arm further argued that Qualcomm should be barred from seeking damages over the leaked termination letter because Qualcomm itself had previously shared confidential details concerning antitrust investigations involving Arm with reporters. Judge Noreika examines Arm licensing negotiations. Running concurrently with the five-day jury trial is a separate bench trial overseen by Judge Noreika. This proceeding examines whether Arm fulfilled its legal obligation to negotiate in good faith regarding the next generation of its chip architecture. Qualcomm's master licensing agreement with Arm runs through 2033. During the bench trial testimony, Qualcomm CEO Cristiano Amon took the stand, where attorneys reviewed a chart indicating that Arm was seeking an increase of 18,500 per cent in royalty payments between version 9 and version 10 of its computing architecture. Arm countered by pressing Amon on whether Qualcomm was simply trying to exploit outdated pricing terms established in a 2013 licensing deal. Arm's legal team pointed out that the 2013 agreement caps royalties at $1.88 per chip for processors with five or more central processing cores. In modern data center silicon featuring up to 288 cores, Arm argued that the old structure leaves Qualcomm paying for only five cores while "getting 283 for free." Amon responded directly to the questioning, stating that I don't see it that way. Commercial stakes and past legal battles between the chip rivals. The current legal friction highlights a broader commercial shift. Arm, traditionally a behind-the-scenes supplier of chip designs to firms such as Qualcomm and Nvidia, has increasingly moved to sell its own branded chips, turning former customers into direct competitors in the artificial intelligence and data center markets, as noted by Stocktwits. Qualcomm accounted for 9% of Arm's total revenue in the fiscal year ended March 31, 2026. Start an LLC Arm disclosed the litigation details in its quarterly financial filings, noting that Qualcomm originally filed the complaint in April 2024, followed by amendments in 2025 and March 2026. Qualcomm stated in its filings that it has not recorded any financial reserves for potential losses from the case, as a negative outcome is not considered probable. This jury trial follows an earlier legal conflict initiated when Arm sued Qualcomm in 2022 over license agreements tied to Qualcomm's acquisition of chip startup Nuvia. While a federal jury ruled largely in Qualcomm's favor in December 2024 - a verdict upheld by a federal court in September 2025 - that case remains on appeal at the United States Court of Appeals for the Third Circuit. The U.S. Federal Trade Commission is investigating Arm Holdings to determine if the semiconductor giant is using its dominant position in chip architecture to unfairly stifle competition, according to people familiar with the matter. The probe centers on whether the British company is leveraging its role as a primary licensor... Learn AI Tools May 16, 2026 August 13, 2026 September 8, 2026